Filing Details
- Accession Number:
- 0000937556-21-000128
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-02 17:20:16
- Reporting Period:
- 2021-10-29
- Accepted Time:
- 2021-11-02 17:20:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 937556 | Masimo Corp | MASI | Electromedical & Electrotherapeutic Apparatus (3845) | 330368882 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1228621 | E Joe Kiani | C/O Masimo Corporation 52 Discovery Irvine CA 92618 | Ceo And Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-10-29 | 18,967 | $290.97 | 11,652 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2021-11-01 | 3,429 | $290.08 | 8,223 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2021-11-02 | 8,223 | $291.46 | 0 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2021-11-02 | 15,223 | $291.46 | 616,986 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 325,185 | Direct | |
| Common Stock | 352,919 | Indirect | By Trust |
| Common Stock | 359,000 | Indirect | By Trust |
| Common Stock | 2,250,291 | Indirect | By Trust |
| Common Stock | 10,368 | Indirect | See Footnote |
| Common Stock | 9,000 | Indirect | See Footnote |
Footnotes
- The shares covered by this Form 4 were sold pursuant to a Rule 10b5-1 Sales Plan dated as of July 29, 2021, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934.
- The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $290.00 per share to a high of $292.60 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held in four trusts for which Mr. Kiani is not the Trustee.
- The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $290.00 per share to a high of $290.27 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $290.00 per share to a high of $292.71 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held in one trust for which Mr. Kiani is the sole Trustee.
- Shares held in Masimo Retirement Savings Plan.
- Shares held by an immediate family member for which Mr. Kiani exercises voting and investment control.
Billionaire Hedge Funds
